Results 131 to 140 of about 21,836 (300)

Comparison of In Vitro Activities of the New Triazole SCH56592 and the Echinocandins MK-0991 (L-743,872) and LY303366 against Opportunistic Filamentous and Dimorphic Fungi and Yeasts [PDF]

, 1998
Ana Espinel‐Ingroff
openalex   +1 more source

Set of Classical PCRs for Detection of Mutations in Candida glabrata FKS Genes Linked with Echinocandin Resistance [PDF]

, 2014
Clinical echinocandin resistance among Candida glabrata strains is increasing, especially in the United States. Antifungal susceptibility testing is considered mandatory to guide therapeutic decisions.
Afeltra, Javier, Dudiuk, Catiana Beatriz, Gamarra, Maria Soledad, Garcia, Guillermo Manuel, Jimenez Ortigoza, Cristina, Leonardelli, Florencia, Perlin, David S., Vitale, Roxana Gabriela   +7 more
core   +2 more sources

Therapeutic Effects of Water-Soluble Echinocandin Compounds on Pneumocystis Pneumonia in Mice [PDF]

, 1998
Takahisa Furuta, Hideyuki Muramatsu, Akihiko Fujie, Shiro Fujihira, Noor Rain Abudullah, Somei Kojima   +5 more
openalex   +1 more source

Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America [PDF]

, 2017
Guidelines for the management of patients with invasive candidiasis and mucosal candidiasis were prepared by an Expert Panel of the Infectious Diseases Society of America.
Andes, David, Benjamin, Daniel K., Calandra, Thierry F., Edwards, John E., Filler, Scott G., Fisher, John F., Kauffman, Carol A., Kullberg, Bart-Jan, Pappas, Peter G., Reboli, Annette C., Rex, John H., Sobe, Jack D., Walsh, Thomas J., Zeichner, Luis Ostrosky   +13 more
core  

The Effect of the Echinocandin Analogue Caspofungin on Cell Wall Glucan Synthesis byCryptococcus neoformans [PDF]

, 2000
Marta Feldmesser, Yvonne Kress, Aron Mednick, Arturo Casadevall   +3 more
openalex   +1 more source

Echinocandins for Pneumocystis jirovecii pneumonia in non-HIV patients: A case report.

Experimental and Therapeutic Medicine, 2018
For the past two decades, echinocandins have shown prophylactic and therapeutic efficacy in patients with Pneumocystis jirovecii pneumonia (PJP), due to their ability to inhibit the synthesis of β-1, 3-glucan, a major component of the cell wall of P ...
Hui-bin Huang, Jing-Min Peng, B. Du
semanticscholar   +1 more source

Efficacy of caspofungin dose escalation against Candida albicans and Candida glabrata clinical isolates [PDF]

, 2016
Munkánk során meghatároztuk a caspofungin által kifejtett ölési rátát RPMI-1640-ben, valamint 50% humán szérummal kiegészített tápközegben C. albicans és C. glabrata klinikai izolátumok ellen.
Domán, Marianna
core  

Deacylation of Echinocandin B by Streptomyces species: a novel method for the production of Echinocandin B nucleus

3 Biotech, 2019
Anidulafungin, a new class of antifungal agent used for the treatment of chronic fungal infections, is derived from Echinocandin B nucleus, an intermediate metabolite of Echinocandin B produced by Aspergillus nidulans. The enzyme acylase plays a key role in the bioconversion of Echinocandin B to Echinocandin B nucleus.
J. Savitha, S. Manohar, M. C. Shivakumar, M. C. Shivakumar, P. Raghu, B. Ishwar   +5 more
openaire   +3 more sources

Membrane-associated echinocandin B deacylase of Actinoplanes utahensis : purification, characterization, heterologous cloning and enzymatic deacylation reaction [PDF]

, 2000
A J Kreuzman, Roland Hodges, James R. Swartling, Tonya Pohl, Sandhya Ghag, Patrick J. Baker, D. I. McGilvray, W K Yeh   +7 more
openalex   +1 more source

Toxicity of LY303366, an Echinocandin Antifungal, in Mice Pretreated with Glucocorticoids [PDF]

, 2000
Karl V. Clemons, Raymond A. Sobel, David A. Stevens   +2 more
openalex   +1 more source